Albert David Friesen

This profile gathers the share dealings of Albert David Friesen across 2 companies, led by Medicure Inc. and Waverley Pharma Inc. Over a trading history stretching from 25 January 2016 to 16 August 2026, the count stands at 137 filings.

Purchases make up the whole of the open-market record (120 purchases, €440k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 option exercise. So far in 2026, the count stands at 5 purchases and no sales.

A typical purchase (the median) is worth €2,214. The 111 purchases reviewed show no overlap with other insiders buying the same stock within a month.

Most recently, on 19 August 2026, the filings show a transaction worth €685k in Waverley Pharma Inc. The latest purchase dates back some time: it was published 123 days ago, on 23 June 2026. Typically, a trade is published a median of 1 day after it takes place. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.